A simplified HPLC method provides an efficient and accurate approach for toxicologic monitoring of adriamycin pharmacokinetics and metabolism in human plasma.
Answers are grounded in this paper and cite their sources.
May enable reliable adriamycin plasma monitoring; leaves open prospective clinical validation of this HPLC assay.
A simplified method is presented for routine toxicologic analysis of the antineoplastic drug, adriamycin, and its major metabolites in human plasma. This method employs a single solvent extraction of plasma using an acetonitrile-aqueous NaOH mixture, followed by reverse-phase isocratic high pressure liquid chromatographic (HPLC) analysis. Recoveries of greater than 95% are obtained for adriamycin and its two major derivatives over the range of concentration: 0.2 to 8.0 nmol/mL of plasma. This method of drug and metabolite isolation and HPLC analysis from human plasma provides an efficient and accurate approach to the individualized toxicologic monitoring of adriamycin pharmacokinetics and metabolism.
No takes yet. Share an insight, caveat, or question.
Quattrone et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: